Urinary concentrations of four parabens in the U.S. Population: NHANES 2005-2006

Environmental Health Perspectives

Volumn 118, Issue 5, 2010, Pages 679-685

  Calafat, Antonia M ^a   Ye, Xiaoyun ^a   Wong, Lee Yang ^a   Bishop, Amber M ^a   Needham, Larry L ^a  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

Biomonitoring; Exposure; Human; NHANES; P hydroxybenzoic acid esters; Urine

Indexed keywords

BUTYL PARABEN; ETHYL PARABEN; METHYL PARABEN; PROPYL PARABEN;

ADOLESCENT; ADULT; ARTICLE; CAUCASIAN; CHILD; ETHNIC DIFFERENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISPANIC; HUMAN; NEGRO; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; RACE DIFFERENCE; SCHOOL CHILD; SEX DIFFERENCE; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; UNITED STATES; URINALYSIS; URINE LEVEL;

ADOLESCENT; ADULT; AGED; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL HEALTH; ENVIRONMENTAL MONITORING; FEMALE; FOOD PRESERVATIVES; HUMANS; MALE; MIDDLE AGED; PARABENS; PRESERVATIVES, PHARMACEUTICAL; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; UNITED STATES; YOUNG ADULT;

EID: 77951759837     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.0901560     Document Type: Article

References (33)

1. Andersen FA. 2008. Final amended report on the safety assessment of methylparaben, ethylparaben, propylparaben, isopropylparaben, butylparaben, isobutylparaben, and benzylparaben as used in cosmetic products. Int J Toxicol 27:1-82.
2. Bando H, Mohri S, Yamashita F, Takakura Y, Hashida M. 1997. Effects of skin metabolism on percutaneous penetration of lipophilic drugs. J Pharm Sci 86:759-761.
3. Bergfeld WE, Belsito DV, Marks JG, Andersen FA. 2005. Safety of ingredients used in cosmetics. J Am Acad Dermatol 52:125-132.
4. Calafat AM, Wong L-Y, Ye X, Reidy JA, Needham LL. 2008a. Concentrations of the sunscreen agent benzophenone-3 in residents of the United States: National Health and Nutrition Examination Survey 2003-2004. Environ Health Perspect 116:893-897.
5. Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL. 2008b. Urinary concentrations of triclosan in the US population: 2003-2004. Environ Health Perspect 116:303-307.
6. CDC (Centers for Disease Control and Prevention). 2009a. General Documentation on Laboratory Data. General Information about the NHANES 2005-2006 Laboratory Methodology and Public Data Files. Available: http://www.cdc.gov/nchs/nhanes/nhanes2005-2006/lab05_06.htm [accessed 2 September 2009].
7. CDC (Centers for Disease Control and Prevention). 2009b. National Health and Nutrition Examination Survey. Available: http://www.cdc.gov/nchs/nhanes/about_nhanes.htm [accessed 2 September 2009].
8. Cowan-Ellsberry CE, Robison SH. 2009. Refining aggregate exposure: example using parabens. Regul Toxicol Pharmacol 55:321-329.
9. Darbre PD. 2006. Environmental oestrogens, cosmetics and breast cancer. Best Practice Res Clin Endocrinol Metabol 20:121-143.
10. Darbre PD, Aljarrah A, Miller WR, Coldham NG, Sauer MJ, Pope GS. 2004. Concentrations of parabens in human breast tumours. J Appl Toxicol 24:5-13.
11. Darbre PD, Harvey PW. 2008. Paraben esters: review of recent studies of endocrine toxicity, absorption, esterase and human exposure, and discussion of potential human health risks. J Appl Toxicol 28:561-578.
12. Duty SM, Ackerman RM, Calafat AM, Hauser R. 2005. Personal care product use predicts urinary concentrations of some phthalate monoesters. Environ Health Perspect 113:1530-1535.
13. El Hussein S, Muret P, Berard M, Makki S, Humbert P. 2007. Assessment of principal parabens used in cosmetics after their passage through human epidermis-dermis layers (ex-vivo study). Exp Dermatol 16:830-836.
14. Elder RL. 1984. Final report on the safety assessment of methylparaben, ethylparaben, propylparaben and butylparaben. J Am Coll Toxicol 3:147-209.
15. Golden R, Gandy J, Vollmer G. 2005. A review of the endocrine activity of parabens and implications for potential risks to human health. Crit Rev Toxicol 35:435-458.
16. Harvey PW, Darbre P. 2004. Endocrine disrupters and human health: could oestrogenic chemicals in body care cosmetics adversely affect breast cancer incidence in women? A review of evidence and call for further research. J Appl Toxicol 24:167-176.
17. Harville HM, Voorman R, Prusakiewicz JJ. 2007. Comparison of paraben stability in human and rat Skin. Drug Metab Lett 1:17-21.
18. Janjua NR, Frederiksen H, Skakkebaek NE, Wulf HC, Andersson AM. 2008. Urinary excretion of phthalates and paraben after repeated whole-body topical application in humans. Int J Androl 31:118-129.
19. Jewell C, Ackermann C, Payne NA, Fate G, Voorman R, Williams FM. 2007a. Specificity of procaine and ester hydrolysis by human, minipig, and rat skin and liver. Drug Metab Dispos 35:2015-2022.
20. Jewell C, Bennett P, Mutch E, Ackermann C, Williams FM. 2007b. Inter-individual variability in esterases in human liver. Biochem Pharmacol 74:932-939.
21. Kiwada H, Awazu S, Hanano M. 1979. Study on the biological fate of paraben at the dose of practical usage in rat. 1. Metabolism and excretion of ethyl para-hydroxybenzoate (ethyl paraben) and para-hydroxybenzoic acid. J Pharmacobio Dyn 2:356-364.
22. Kiwada H, Awazu S, Hanano M. 1980. The study on the biological fate of paraben at the dose of practical usage in rat. 2. The pharmacokinetic study on the blood-concentration after the administration of ethyl paraben or para-hydroxybenzoic acid. J Pharmacobio Dyn 3:353-363.
23. National Toxicology Program. 2004. Butylparaben [CAS No. 94-26-8]. Final Review of Toxicological Literature. Available: http://ntp.niehs.nih.gov/files/Butylparaben.pdf [accessed 15 December 2009].
24. National Toxicology Program. 2006. NTP Concept Document. Butylparaben. Available: http://ntp.niehs.nih.gov/files/ButylparabenConcept.pdf [accessed 15 December 2009].
25. Prusakiewicz JJ, Ackermann C, Voorman R. 2006. Comparison of skin esterase activities from different species. Pharm Res 23:1517-1524.
26. Sandborgh-Englund G, Adolfsson-Erici M, Odham G, Ekstrand J. 2006. Pharmacokinetics of triclosan following oral ingestion in humans. J Toxicol Environ Health A 69:1861-1873.
27. SCCP (Scientific Committee on Consumer Products). 2005. SCCP/0874/05-Extended Opinion on Parabens, Underarm Cosmetics and Breast Cancer, Adopted by the SCCP by Written Procedure on 28 January 2005. Brussels:European Commission.
28. SCCP (Scientific Committee on Consumer Products). 2008. Scientific Committee on Consumer Products Opinion on: Parabens COLIPA no. P82 Adopted by the SCCP during the 16th Plenary Meeting on 24 June 2008. Brussels:European Commission.
29. Silva MJ, Barr DB, Reidy JA, Malek NA, Hodge CC, Caudill SP, et al. 2004. Urinary levels of seven phthalate metabolites in the US population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000. Environ Health Perspect 112:331-338.
30. Soni MG, Carabin IG, Burdock GA. 2005. Safety assessment of esters of p-hydroxybenzoic acid (parabens). Food Chem Toxicol 43:985-1015.
31. Taylor JK. 1987. Quality Assurance of Chemical Measurements. Chelsea, MI:Lewis Publishers.
32. Ye XY, Bishop AM, Reidy JA, Needham LL, Calafat AM. 2006a. Parabens as urinary biomarkers of exposure in humans. Environ Health Perspect 114:1843-1846.
33. Ye XY, Kuklenyik Z, Bishop AM, Needham LL, Calafat AM. 2006b. Quantification of the urinary concentrations of parabens in humans by on-line solid phase extraction-high performance liquid chromatography-isotope dilution tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 844:53-59.